174 related articles for article (PubMed ID: 1892302)
21. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
Smith LJ; Hanby LA; Lavins BJ; Simonson SG
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
[TBL] [Abstract][Full Text] [Related]
22. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
Kaye MG; Smith LJ
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659
[TBL] [Abstract][Full Text] [Related]
23. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
[TBL] [Abstract][Full Text] [Related]
24. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
25. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of leukotriene D4-induced bronchoconstriction in normal subject.
Smith LJ; Kern R; Patterson R; Krell RD; Bernstein PR
J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):340-7. PubMed ID: 3624684
[TBL] [Abstract][Full Text] [Related]
27. Effect of BAY x 7195, an oral receptor antagonist of cysteinyl-leukotrienes, on leukotriene D4-induced bronchoconstriction in normal volunteers.
Wensing G; Heinig R; Priesnitz M; Kuhlmann J
Eur J Clin Pharmacol; 1994; 47(3):227-30. PubMed ID: 7867675
[TBL] [Abstract][Full Text] [Related]
28. Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects.
Fuller RW; Black PN; Dollery CT
J Allergy Clin Immunol; 1989 May; 83(5):939-44. PubMed ID: 2715552
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of bronchoconstriction induced by neurokinins and its inhibition by selective nonpeptide antagonists in conscious guinea pigs, using a double-chamber plethysmograph technique.
Chan CC; Tousignant C; Ho E; Brideau C; Savoie C; Rodger IW
Can J Physiol Pharmacol; 1994 Jan; 72(1):11-8. PubMed ID: 8012892
[TBL] [Abstract][Full Text] [Related]
30. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.
Christie PE; Smith CM; Lee TH
Am Rev Respir Dis; 1991 Oct; 144(4):957-8. PubMed ID: 1928974
[TBL] [Abstract][Full Text] [Related]
31. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
Young RN
Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the airway response to inhaled leukotriene D4 in normal subjects.
Kern R; Smith LJ; Patterson R; Krell RD; Bernstein PR
Am Rev Respir Dis; 1986 Jun; 133(6):1127-32. PubMed ID: 3521417
[TBL] [Abstract][Full Text] [Related]
33. LTD4-induced bronchoconstriction in patients with asthma: lack of a vagal reflex.
Ayala LE; Choudry NB; Fuller RW
Br J Clin Pharmacol; 1988 Jul; 26(1):110-2. PubMed ID: 2849473
[TBL] [Abstract][Full Text] [Related]
34. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.
Joos GF; Van Schoor J; Kips JC; Pauwels RA
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1781-4. PubMed ID: 8665034
[TBL] [Abstract][Full Text] [Related]
35. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
Schelfhout V; Van De Velde V; Pauwels R; Joos G
Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
Smith LJ; Glass M; Minkwitz MC
Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
[TBL] [Abstract][Full Text] [Related]
37. Immediate hypersensitivity reactions in the guinea-pig conjunctiva: studies with a second-generation leukotriene D4 receptor antagonist, MK-571.
Chan CC; Dagenais F; Firby P; Foster A; Ford-Hutchinson AW
Can J Physiol Pharmacol; 1989 Aug; 67(8):845-50. PubMed ID: 2557140
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
Crimi N; Pagano C; Palermo F; Mastruzzo C; Prosperini G; Pistorio MP; Vancheri C
J Allergy Clin Immunol; 2003 Apr; 111(4):833-9. PubMed ID: 12704366
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo effect of verapamil on human airway responsiveness to leukotriene D4.
Roberts JA; Giembycz MA; Raeburn D; Rodger IW; Thomson NC
Thorax; 1986 Jan; 41(1):12-6. PubMed ID: 3518128
[TBL] [Abstract][Full Text] [Related]
40. Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma.
Roberts JA; Rodger IW; Thomson NC
Thorax; 1986 Oct; 41(10):753-8. PubMed ID: 3097863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
